We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 63

EPO Enlarged Board of Appeal rejects patent that requires human embryos for implementation

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • December 31 2008

In its decision of 25 November 2008 the EPO Enlarged Board of Appeal (EBA) considered four questions referred to it by the EPO Technical Board of Appeal concerning a patent application by Wisconsin Alumni Research Foundation (WARF) with claims to “a cell culture comprising primate embryonic stem cells…”

End of German Olanzapine battle: Federal Supreme Court upholds patent

  • Bird & Bird
  • -
  • Germany
  • -
  • March 11 2009

On December 16, 2008 the Federal Supreme Court gave its judgment determining the validity of the Olanzapine patent, this was further to its revocation by the Federal Patent Court at first instance

Paedriatric SPC extension: zero or negative term SPCs

  • Bird & Bird
  • -
  • European Union, United Kingdom
  • -
  • March 11 2009

Zero or negative term SPCs give rise to a unique disunity amongst the granting authorities in the European Member States

Preliminary injunctions in pharmaceutical patent actions

  • Bird & Bird
  • -
  • Italy
  • -
  • May 13 2009

By a decision of 15 April 2009 issued in a preliminary injunction proceeding, the Court of Milan held that the mere grant of a Marketing Authorisation (MA) for a generic pharmaceutical product does not constitute an imminent threat of patent infringement

Commission pharma sector enquiry and initiation of formal proceedings against Servier and others

  • Bird & Bird
  • -
  • European Union
  • -
  • July 17 2009

On 8 July 2009, as this update was being finalised, the European Commission published its final report on its inquiry into the pharmaceutical sector

New regulations for medical devices

  • Bird & Bird
  • -
  • Spain
  • -
  • December 15 2009

On 6 November 2009, two new regulations reshaping the framework for medical devices were published in the Spanish Official Gazette

Generics in France: towards an exemption from trade mark rights and a two-tier system?

  • Bird & Bird
  • -
  • France
  • -
  • December 15 2009

On 26 November 2009, the French Senate voted on the law on ‘Financing the National Social Security for 2010’

Protection of dosage regiment for medicaments under the new European Patent Convention 2000

  • Bird & Bird
  • -
  • European Union
  • -
  • July 16 2008

The discussion before the European Patent Office on patentability of second medical use claims has now entered another round

Patent settlements under the authorities’ magnifying glass

  • Bird & Bird
  • -
  • European Union
  • -
  • December 15 2009

Drug prices are currently a key area of discussion in many countries around the globe

New regulatory requirements in the pharmaceutical sector

  • Bird & Bird
  • -
  • European Union
  • -
  • October 30 2008

Regulation (EC) No 19012006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use (hereinafter, “the Paediatric Regulation”) is intended to tackle the problems resulting from the absence of suitably adapted medicinal products for the paediatric population (including inadequate dosage information, non-availability to the paediatric population of therapeutic advances, suitable formulations and routes of administration as well as use of magistral or officinal formulations to treat the paediatric population